Nasdaq · CIK 0001093557
DXCM DEXCOM INC
Insider trading from SEC Form 4. Last filing Dec 17, 2024.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
4
with a Form 4 at this company
Signals
Open-market buys and sells at DEXCOM INC, scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 18Weak | sell 410b5-1 | Heller Bridgette P director | $77k | 1,000 | -4% | - | |
| 42Moderate | sell 4 | Leach Jacob Steven EVP, Chief Operating Officer | $57k | 744 | -0% | - | |
| 44Moderate | sell 4 | Sylvain Jereme M EVP, Chief Financal Officer | $57k | 744 | -1% | - | |
| 36Weak | sell 4 | Stern Sadie EVP, Chief HR Officer | $33k | 424 | -1% | - | |
| 37Weak | sell 2 | Stern Sadie EVP, Chief HR Officer | $318k | 4,259 | -6% | - | |
| 23Weak | sell 210b5-1 | Sylvain Jereme M EVP, Chief Financal Officer | $264k | 3,500 | -4% | - |
Congressional trades
10 trades in DXCM disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Tina Smith Senate · D-MN | Sale | DXCM DexCom, Inc. - Common Stock | $100k to $250k | May 7, 2026 | 3 days after the trade |
| Tina Smith Senate · D-MN | Partial sale | DXCM DexCom, Inc. - Common Stock | $100k to $250k | Apr 29, 2026 | 11 days after the trade |
| John Boozman Senate · R-AR | Purchase | DXCM Dexcom Inc | $1,001 to $15k | Jan 26, 2026 | 20 days after the trade |
| Jefferson Shreve House · R-IN | Purchase | DXCM DexCom, Inc. - Common Stock | $15k to $50k | May 8, 2025 | 45 days after the trade |
| Jefferson Shreve House · R-IN | Sale | DXCM DexCom, Inc. - Common Stock | $15k to $50k | May 12, 2025 | 41 days after the trade |
| Robert P. Bresnahan, Jr. House · R-PA | Purchase | DXCM DexCom, Inc. - Common Stock | $1,001 to $15k | May 15, 2025 | 25 days after the trade |
| Jefferson Shreve House · R-IN | Sale | DXCM DexCom, Inc. - Common Stock | $15k to $50k | Apr 7, 2025 | 31 days after the trade |
| Robert P. Bresnahan, Jr. House · R-PA | Sale | DXCM DexCom, Inc. - Common Stock | $1,001 to $15k | Apr 8, 2025 | 20 days after the trade |
| Robert P. Bresnahan, Jr. House · R-PA | Purchase | DXCM DexCom, Inc. - Common Stock | $1,001 to $15k | Feb 25, 2025 | 30 days after the trade |
| Kevin Hern House · R-OK | Sale | DXCM DexCom, Inc. - Common Stock | $50k to $100k | Dec 31, 2024 | 15 days after the trade |
Transactions
The last 6 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 16, 2024 | Heller Bridgette P director | SOpen-market sale Common Stock10b5-1 | -1,000 | $76.87 | $77k | 23,349 | Dec 17, 2024 |
| Dec 16, 2024 | Leach Jacob Steven EVP, Chief Operating Officer | SOpen-market sale Common Stock | -744 | $76.87 | $57k | 264,171 | Dec 17, 2024 |
| Dec 16, 2024 | Sylvain Jereme M EVP, Chief Financal Officer | SOpen-market sale Common Stock | -744 | $76.87 | $57k | 80,030 | Dec 17, 2024 |
| Dec 16, 2024 | Stern Sadie EVP, Chief HR Officer | SOpen-market sale Common Stock | -424 | $76.87 | $33k | 70,768 | Dec 17, 2024 |
| Nov 20, 2024 | Stern Sadie EVP, Chief HR Officer | SOpen-market sale Common Stock | -4,259 | $74.73 | $318k | 71,192 | Nov 22, 2024 |
| Nov 15, 2024 | Sylvain Jereme M EVP, Chief Financal Officer | SOpen-market sale Common Stock10b5-1 | -3,500 | $75.51 | $264k | 80,774 | Nov 18, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Heller Bridgette Pdirector
- Leach Jacob StevenEVP, Chief Operating Officer
- Stern SadieEVP, Chief HR Officer
- Sylvain Jereme MEVP, Chief Financal Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.